Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

• Status: Terminated
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To test the effect of the research study drug, inhaled fluticasone on lung function in exercising patients with Chronic Obstructive Pulmonary Disease (COPD).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Fluticasone

Criteria

Inclusion Criteria:

• 40 years and older

• Clinical diagnosis of COPD for greater than one year

• History of cigarette smoking

Exclusion Criteria:

• Other lung diseases (not including COPD), such as asthma

• A condition that could interfere with your ability to perform exercise tests